tirzepatide news november 2025 Pennington Biomedical Research Center Investigates Tirzepatide's Role in Weight Loss and Metabolic Health FDA approval for Zepbound (tirzepatide)

doi: 10.1126/science.aaz5891 Summary Keywords adverse reactions and cases, case report, depression, semaglutide, weight loss Citation Li J-R, Cao J, Wei J and Geng W (2023) Case Report: Semaglutide-associated depression: a report of two cases

Use in individuals under 18 is not recommended without specific medical supervision

The American College of Physicians emphasizes shared decision-making in obesity management, making open communication about treatment experience, including hunger, an essential component of successful outcomes with medications like Zepbound

Kelly, K

Why might a provider prescribe a compounded medication instead of a branded one

CFP and YFP coding DNA was amplified by polymerase chain reaction from pDH18 vector (YRC, Washington, USA)